Clinical Trials Browser

INDUSTRY × Has results × ibritumomab tiuxetan × Clear all

NCT04189588 2023-10-06

versus

Phase 2 Completed

34 enrolled 11 charts

Oncology Patients Receiving Chemotherapy

NCT00322218 2022-01-19

Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.

Phase 3 Terminated

68 enrolled 9 charts

Lymphoma, Large B-Cell, Diffuse

NCT01510184 2021-12-16

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Phase 3 Terminated

79 enrolled 9 charts

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT01549886 2021-10-04

Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma

Phase 2 Terminated

5 enrolled 8 charts

Lymphoma, Non-Hodgkin

NCT01662102 2021-10-04

Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)

Phase 3 Terminated

1 enrolled 1 chart

Lymphoma, Follicular